TMO vs XAIR · P/E 24, rev $23.00B vs rev $7.7M
Thermo Fisher Scientific Inc (TMO) versus Beyond Air Inc (XAIR) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US. It is led by Marc N. Casper.
Beyond Air Inc (XAIR) is a medical devices company listed on US.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported XAIR revenue for 2026-03-31 was $7.7M. Net income was -$33.2M. Revenue was up 107.3% from 2025-03-31 to 2026-03-31. XAIR currently screens at market cap $16.0M.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. XAIR currently screens at market cap $16.0M.
Not investment advice. Open the TMO and XAIR stock pages for the full models.
Not investment advice.